Alkermes (ALKS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
28.50
0.15 (0.53%)
At close: Jan 14, 2025, 3:59 PM
29.30
2.79%
Pre-market Jan 15, 2025, 06:42 AM EST
Alkermes Revenue Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aristada And Aristada Initio Revenue | 84.65M | 86.05M | 78.87M | 247.61M | 80.08M | 79.23M | 74.62M | 72.48M | 78.66M | 68.87M | 72.39M | 55.43M | 148.96M | 142.66M | 130.41M | 129.73M | 138.77M | 136.63M | 99.48M | 83.83M | 79.89M | 76.20M |
Aristada And Aristada Initio Revenue Growth | -1.62% | +9.10% | -68.15% | +209.22% | +1.07% | +6.17% | +2.95% | -7.85% | +14.21% | -4.86% | +30.60% | -62.79% | +4.42% | +9.39% | +0.53% | -6.52% | +1.57% | +37.35% | +18.67% | +4.93% | +4.84% | n/a |
L Y B A L V I Revenue | 74.70M | 71.35M | 57.01M | 153.90M | 37.99M | 34.91M | 20.06M | 13.93M | 178.92M | 157.74M | 160.81M | 129.96M | n/a | n/a | 71.65M | 78.77M | 85.16M | n/a | n/a | n/a | n/a | n/a |
L Y B A L V I Revenue Growth | +4.69% | +25.16% | -62.96% | +305.09% | +8.84% | +74.01% | +44.02% | -92.21% | +13.43% | -1.91% | +23.73% | n/a | n/a | n/a | -9.04% | -7.51% | n/a | n/a | n/a | n/a | n/a | n/a |
Product Revenue | 273.00M | 269.27M | 233.54M | 705.27M | 214.73M | 216.12M | 190.79M | 171.27M | 92.04M | 88.86M | 88.42M | 74.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Product Revenue Growth | +1.38% | +15.30% | -66.89% | +228.45% | -0.64% | +13.28% | +11.40% | +86.08% | +3.57% | +0.51% | +18.63% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vivitrol Revenue | 113.65M | 111.87M | 97.66M | 303.76M | 96.66M | 101.98M | 96.11M | 84.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vivitrol Revenue Growth | +1.59% | +14.55% | -67.85% | +214.26% | -5.22% | +6.12% | +13.26% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Mar 31, 2013 | Mar 31, 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Foreign Country Excluding Specified Country Revenue | 170.29M | 177.97M | 187.34M | 196.53M | 200.82M | 204.76M | 193.58M | 183.97M | 175.79M | 212.91M | 14.46M | 12.70M |
Foreign Country Excluding Specified Country Revenue Growth | -4.32% | -5.00% | -4.67% | -2.14% | -1.92% | +5.78% | +5.22% | +4.65% | -17.43% | +1372.91% | +13.86% | n/a |
Ireland Revenue | 1.18M | 1.83M | 2.17M | 3.23M | 3.19M | 4.92M | n/a | n/a | n/a | n/a | 380.56M | 212.86M |
Ireland Revenue Growth | -35.54% | -15.91% | -32.73% | +1.19% | -34.99% | n/a | n/a | n/a | n/a | n/a | +78.79% | n/a |
United States Revenue | 1.49B | 931.99M | 984.24M | 839.00M | 966.93M | 884.60M | n/a | n/a | n/a | n/a | n/a | n/a |
United States Revenue Growth | +60.08% | -5.31% | +17.31% | -13.23% | +9.31% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 150.38M | 168.11M | 179.75M | 169.79M | 169.45M | 205.26M | 174.48M | 157.54M | 152.78M | 150.38M | 145.05M | 160.41M | 136.21M | 139.19M | 125.17M | 145.78M | 127.65M | 132.03M | 133.37M | 154.45M | 148.70M | 155.07M | 141.22M | 141.23M | 128.78M | 138.26M | 118.15M | 110.90M | 99.63M | 108.95M | 102.10M | 97.14M | 91.14M | 96.12M | 89.72M | 87.47M | 89.50M | 71.54M | 63.05M |
Selling, General, and Administrative Revenue Growth | -10.55% | -6.47% | +5.87% | +0.20% | -17.45% | +17.64% | +10.75% | +3.12% | +1.60% | +3.67% | -9.57% | +17.76% | -2.14% | +11.20% | -14.14% | +14.20% | -3.31% | -1.01% | -13.65% | +3.87% | -4.11% | +9.81% | n/a | +9.67% | -6.86% | +17.02% | +6.54% | +11.30% | -8.55% | +6.71% | +5.10% | +6.58% | -5.18% | +7.14% | +2.57% | -2.26% | +25.10% | +13.46% | n/a |
Research and Development Revenue | 59.89M | 58.25M | 66.21M | 73.93M | 97.14M | 7.00K | 93.64M | 104.59M | 36.00K | 92.87M | 107.00K | 1.02M | 110.00K | 615.00K | 120.00K | 1.95M | 953.00K | 609.00K | 243.00K | 52.82M | 12.69M | 14.34M | 14.71M | 68.89M | 16.27M | 18.34M | 18.71M | 7.23M | 1.03M | 833.00K | 643.00K | 2.30M | 189.00K | 612.00K | 1.24M | 4.02M | 678.00K | 1.04M | 1.33B |
Research and Development Revenue Growth | +2.82% | -12.03% | -10.44% | -23.89% | +1387614.29% | -99.99% | -10.47% | +290416.67% | -99.96% | +86697.20% | -89.51% | +827.27% | -82.11% | +412.50% | -93.83% | +104.20% | +56.49% | +150.62% | -99.54% | +316.33% | -11.53% | -2.49% | -78.65% | +323.34% | -11.28% | -1.94% | +158.67% | +604.19% | +23.29% | +29.55% | -72.06% | +1117.46% | -69.12% | -50.68% | -69.12% | +492.77% | -34.56% | -99.92% | n/a |
Sales and Marketing Revenue | 102.10M | 119.70M | 125.60M | 116.30M | 114.80M | 137.90M | 118.50M | -288.40M | 96.90M | 95.30M | 96.20M | -253.40M | 88.00M | 85.70M | 79.70M | -87.80M | 79.00M | 82.90M | 87.80M | 31.10M | n/a | n/a | 90.70M | 54.70M | n/a | n/a | n/a | 34.40M | n/a | n/a | n/a | 24.00M | n/a | n/a | n/a | 10.60M | n/a | n/a | n/a |
Sales and Marketing Revenue Growth | -14.70% | -4.70% | +8.00% | +1.31% | -16.75% | +16.37% | -141.09% | -397.63% | +1.68% | -0.94% | -137.96% | -387.95% | +2.68% | +7.53% | -190.77% | -211.14% | -4.70% | -5.58% | +182.32% | n/a | n/a | -100.00% | +65.81% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |